PI3Kγ is involved in Akt/mTOR signaling, inhibition of NF-κB activation, and in the regulation of tumor immune inhibition by promoting MDSC migration to the tumor environment as well as by stimulating the immunosuppressive transformation of MDSCs [19]. The gene discussed is AKT1; the disease is neoplasm.